Physician profile
Thomas J Morrison, III
NPI 1003909649
$2,773,865.53
in general payments reported to CMS, 2019-2025
7 companies · $93K in 2025
The $93K reported for 2025 was more than what 97% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $630K · 2020: $618K · 2021: $388K · 2022: $355K · 2023: $333K · 2024: $356K · 2025: $93K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $782K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $782,425.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,205,751.50 | 2019-2025 | Cascadia Interbody System |
| Depuy Synthes Products, INC. | $567,253.82 | 2019-2020 | |
| Republic Spine | $300.16 | 2019 | |
| Spine Wave, INC. | $161.07 | 2019 | |
| Medicrea USA, Corp. | $148.94 | 2019 | |
| Stability Biologics, LLC | $135.00 | 2019 | |
| Depuy Synthes Sales INC. | $115.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.